Contact
Please use this form to send email to PR contact of this press release:
Sorrento Acquires the Sofusa™ Lymphatic Delivery Platform for Immune-Oncology (I-O) Antibody Therapeutics
TO:
Please use this form to send email to PR contact of this press release:
Sorrento Acquires the Sofusa™ Lymphatic Delivery Platform for Immune-Oncology (I-O) Antibody Therapeutics
TO: